首页> 外文期刊>Toxicology: An International Journal Concerned with the Effects of Chemicals on Living Systems >Effects of lead administration at low doses by different routes on rat spleens. Study of response of splenic lymphocytes and tissue lysozyme.
【24h】

Effects of lead administration at low doses by different routes on rat spleens. Study of response of splenic lymphocytes and tissue lysozyme.

机译:低剂量铅通过不同途径给药对大鼠脾脏的影响。脾淋巴细胞和组织溶菌酶反应的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to evaluate the effects of low doses of lead (200 ppm of PbAc(2) for 4 weeks) on rat spleens using different routes of administration. The study has been carried out at different levels: a histological evaluation has been made, and alterations of cell proliferation, B and T lymphocyte subpopulations, and CD4(+) and CD8(+) T cell subpopulations have been evaluated. Apoptosis and necrosis of lymphoid cells were also analysed. Furthermore, lysozyme activity was measured. Results indicate a large increase in spleen size when lead is administered by intraperitoneal injection, being this route in which lead causes larger modifications in all of the parameters measured. Lead administered orally causes histological modifications, such as an increase in the number of lymphocytes as well as edema. However, significant alterations in other parameters studied have not been detected. Lead administration by intraperitoneal route causes more evident histological modifications as well as an increase in the number of lymphocytes, and also induces a decrease in the percentage of B(+), T(+) and CD4(+) cells, and an increase in CD8(+) cells. Cell death of splenic lymphocytes is not altered by lead. With regard to the immune innate response, lead behaves as an immunomodulator as can be deduced from data on lysozyme activity in tissue. Therefore, it is possible to affirm that the effect of low doses of lead depends on the route of administration. Thus, the intraperitoneal route, through which lead goes directly to the bloodstream, causes drastic effects, generating important immunological alterations.
机译:这项研究的目的是评估使用不同给药途径的低剂量铅(200 ppm PbAc(2),持续4周)对大鼠脾脏的影响。该研究已在不同的水平上进行:已经进行了组织学评估,并评估了细胞增殖,B和T淋巴细胞亚群以及CD4(+)和CD8(+)T细胞亚群的变化。还分析了淋巴样细胞的凋亡和坏死。此外,测量了溶菌酶活性。结果表明,当通过腹膜内注射施用铅时,脾脏大小会大大增加,这是铅导致所有所测参数发生较大变化的途径。口服铅会导致组织学改变,例如淋巴细胞数量增加和浮肿。但是,尚未检测到其他研究参数的重大变化。通过腹膜内途径进行铅给药会导致更明显的组织学改变以及淋巴细胞数量的增加,并且还会导致B(+),T(+)和CD4(+)细胞百分比的降低以及B(+)细胞的增加。 CD8(+)细胞。铅不会改变脾脏淋巴细胞的细胞死亡。关于免疫的先天应答,如从组织中溶菌酶活性的数据可以推断出的,铅起免疫调节剂的作用。因此,可以确认低剂量铅的效果取决于给药途径。因此,铅直接通过其进入腹膜腔的腹膜内途径引起了巨大的影响,产生了重要的免疫学改变。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号